BMJ 1996;313:1124-1126 (2 November)

General practice

Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions

Michael Shelley, research pharmacist,a Peter Croft, professor of epidemiology,a Stephen Chapman, director of prescribing analysis,b Charles Pantin, senior lecturer, consultant physician a

a Industrial and Community Health Research Centre, School of Postgraduate Medicine, Keele University, North Staffordshire Medical Institute, Stoke on Trent ST4 7NY, b Department of Medicines Management (formerly the Department of Pharmacy Policy and Practice), Keele University, Keele, Staffordshire ST5 5BG

Correspondence to: Mr Shelley.

Abstract

Objective: To investigate the ratio of inhaled corticosteroid to bronchodilator as a measure of the quality of asthma prescribing by general practitioners.
Design: Ecological cross sectional study linking general practitioner asthma prescribing with hospital admission data and a measure of deprivation.
Subjects: 11 family health services authorities in the West Midlands region and 99 general practices in North Staffordshire.
Main outcome measures: Hospital admission rates for asthma; the ratio of inhaled corticosteroid to bronchodilator; and Townsend deprivation scores.
Results: No overall significant correlation was found between admission rates for asthma and corticosteroid:bronchodilator ratios for family health services authorities (Spearman's rs = -0.109, P = 0.750) or general practices (rs = -0.084, P = 0.407). In deprived family health services authority areas and general practices an inverse non-significant correlation existed between admission rates for asthma and corticosteroid:bronchodilator ratios (rs = -0.300, P = 0.624; rs = -0.218, P = 0.136). In contrast, in more affluent areas and general practices a positive non-significant correlation existed between admission rates and corticosteroid:bronchodilator ratios (rs = 0.371, P = 0.468; rs = 0.038, P = 0.792).
Conclusion: Although the corticosteroid:bronchodilator ratio may be a valid indicator of the quality of prescribing for individual patients with asthma, caution should be applied in interpreting aggregated ratios. Differences in the severity of asthma or the prevalence of chronic obstructive pulmonary disease may explain inconsistent associations between admission rates for asthma and corticosteroid:bronchodilator ratios in family health services authorities and general practices with different deprivation scores.

Key messages

  • The use of the corticosteroid:bronchodilator ratio as an indicator of the qual- ity of asthma prescribing at family health services authority or general practice level should be viewed with caution.

  • The association between corticosteroid:bronchodilator ratios and hospital admission rates for asthma shows inconsistency between deprived and more affluent areas.

  • Differences in asthma severity or the prevalence of chronic obstructive pulmo- nary disease may offer explanations for this inconsistency.

  • Individual prescribing data linked to more accurate measures of asthma mor- bidity and the general practitioner's diagnosis are required.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Schatz, M., Zeiger, R. S., Vollmer, W. M., Mosen, D., Mendoza, G., Apter, A. J., Stibolt, T. B., Leong, A., Johnson, M. S., Cook, E. F. (2006). The Controller-to-Total Asthma Medication Ratio Is Associated With Patient-Centered As Well As Utilization Outcomes.. Chest 130: 43-50 [Abstract] [Full text]  
  • Schatz, M., Nakahiro, R., Crawford, W., Mendoza, G., Mosen, D., Stibolt, T. B. (2005). Asthma Quality-of-Care Markers Using Administrative Data. Chest 128: 1968-1973 [Abstract] [Full text]  
  • Love, T., Dowell, A. C, Salmond, C., Crampton, P. (2004). Quality indicators and variation in primary care: modelling GP referral patterns. Fam Pract 21: 160-165 [Abstract] [Full text]  
  • Glauber, J. H., Fuhlbrigge, A. L., Finkelstein, J. A., Homer, C. J., Weiss, S. T. (2001). Relationship Between Asthma Medication and Antibiotic Use. Chest 120: 1485-1492 [Abstract] [Full text]  
  • Lagerlov, P., Hjortdahl, P., Saxegaard, L., Andrew, M., Matheson, I. (2001). Structuring prescribing data into traffic-light categories; a tool for evaluating treatment quality in primary care. Fam Pract 18: 528-533 [Abstract] [Full text]  
  • Walley, T, Bundred, P, Rannard, A, Bogg, J (1999). Classic therapies revisited: Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma. Postgrad. Med. J. 75: 710-714 [Abstract] [Full text]  
  • Goodman, D. C., Lozano, P., Stukel, T. A., Chang, C.-h., Hecht, J. (1999). Has Asthma Medication Use in Children Become More Frequent, More Appropriate, or Both?. Pediatrics 104: 187-194 [Abstract] [Full text]  
  • Hansell, A., Hollowell, J., Nichols, T., McNiece, R., Strachan, D. (1999). Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 54: 413-419 [Abstract] [Full text]  
  • Majeed, A., Evans, N., Head, P. (1997). What can PACT tell us about prescribing in general practice?. BMJ 315: 1515-1519 [Full text]  
  • Roberts, S. J, Baumer, J H, Currie, C. J, Evans, M., Morgan, C. L, Griffiths, C., Sturdy, P., Naish, J., Feder, G., Omar, R., Dolan, S., Pereira, F., Shelley, M., Croft, P., Pantin, C., Chapman, S. (1997). Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. BMJ 314: 680-680 [Full text]  



Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview